Effects of vaccination on invasive pneumococcal disease in South Africa
GHDx Entry last modified on: Mar 3, 2019
Pneumococcal pneumonia
Dataset Records for Pneumococcal pneumonia
Displaying 51 - 100 of 340
Impact of the antipneumococcal conjugate vaccine on the occurrence of infectious respiratory diseases and hospitalization rates in children
GHDx Entry last modified on: Mar 3, 2019
Risk factors of A/H1N1 etiology in pneumonia and its impact on mortality
GHDx Entry last modified on: Feb 7, 2020
Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted to secondary hospitals
GHDx Entry last modified on: Mar 3, 2019
Hospitalized children with pneumonia in Uruguay: pre and post introduction of 7 and 13-valent pneumococcal conjugated vaccines into the National Immunization Program
GHDx Entry last modified on: Mar 3, 2019
United States Active Bacterial Core Surveillance Report, Group A Streptococcus 2009
Active Bacterial Core Surveillance (ABCs) Report, Emerging Infections Program Network, Group A Streptococcus, 2009
United States Active Bacterial Core Surveillance Report, Group A Streptococcus 2008
Active Bacterial Core Surveillance (ABCs) Report, Emerging Infections Program Network, Group A Streptococcus, 2008
Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia
GHDx Entry last modified on: Apr 30, 2021
Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged ≥60 Years: 3 Years of Follow-up in the CAPAMIS Study
GHDx Entry last modified on: Jan 12, 2022
Clinical features of adults with seven-valent-conjugated-vaccine-serotype pneumococcal pneumonia
GHDx Entry last modified on: Jul 20, 2021
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults
GHDx Entry last modified on: Jan 12, 2022
Impact of pneumococcal vaccine on invasive pneumococcal disease among young children in the Mid-West region of Ireland
GHDx Entry last modified on: Jun 14, 2021
Impact of the 2009 influenza A H1N1 pandemic on invasive pneumococcal disease in adults
GHDx Entry last modified on: Sep 6, 2019
Effect of PCV10 Vaccination on pneumococcal serotypes in Brazil using the national pneumococcal laboratory network surveillance
GHDx Entry last modified on: Jun 14, 2021
Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: an evaluation using existing data
GHDx Entry last modified on: Mar 3, 2019
Argentina Annual Epidemiological Bulletin 2009
Boletín Epidemiológico Anual, Edición Anual 2009
Acute otitis media and pneumonia in young children in Iceland: an early reduction of incidence after PCV-10 immunization
GHDx Entry last modified on: Aug 9, 2021
Neumonía adquirida en la comunidad
GHDx Entry last modified on: Mar 3, 2019
Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study
GHDx Entry last modified on: Mar 3, 2019
Four years laboratory-based surveillance of invasive pneumcoccal disases in Morocco: what impacts of the pneumococcal conjugate vaccine in Moroccan population?
GHDx Entry last modified on: Jun 14, 2021
Serotype evolution and antimicrobial susceptibility of IPD pre and post introduction of 13-valent pneumococcal conjugate vaccine (PCV13) in Greece
GHDx Entry last modified on: Jun 14, 2021
Effectiveness of 23-valent pneumococcal polysaccharide vaccine in adults aged 60 years and over in the Region of Madrid, Spain, 2008-2011
GHDx Entry last modified on: Mar 3, 2019
The impact of heptavalent pneumococcal conjugate vaccine on the incidence of childhood community-acquired pneumonia and bacteriologically confirmed pneumococcal pneumonia in Japan
GHDx Entry last modified on: Mar 3, 2019
Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China
GHDx Entry last modified on: Sep 6, 2019
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
GHDx Entry last modified on: Mar 3, 2019
Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia
GHDx Entry last modified on: Mar 3, 2019
High incidence of community-acquired pneumonia among rapidly aging population in Japan: a prospective hospital-based surveillance
GHDx Entry last modified on: Oct 9, 2019
Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in Taiwan
GHDx Entry last modified on: Mar 3, 2019
Impact of 13-valent pneumococcal conjugate vaccine on a population at high risk for invasive pneumococcal disease
GHDx Entry last modified on: Jun 14, 2021
United States National Health and Nutrition Examination Survey 2007-2008
Survey:
Cross-sectional - Exam - Household - Individual - Interview - Nationally representative
By age group incidence of invasive pneumococcal disease after withdrawal of PCV13 from the pediatric universal vaccination calendar in Madrid
GHDx Entry last modified on: Jan 12, 2022
Surveillance for hospitalized acute respiratory infection in Guatemala
GHDx Entry last modified on: Feb 7, 2020
The incidence and etiology of community-acquired pneumonia in fever outpatients
GHDx Entry last modified on: Mar 3, 2019
Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goiânia, Brazil
GHDx Entry last modified on: Mar 11, 2024
Atypical pathogens causing community-acquired pneumonia in adults
GHDx Entry last modified on: Jul 20, 2021
Etiology and Incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007-2010
GHDx Entry last modified on: Mar 3, 2019
United States Active Bacterial Core Surveillance Report, Group A Streptococcus 2007
Active Bacterial Core Surveillance (ABCs) Report, Emerging Infections Program Network, Group A Streptococcus, 2007
Viral and bacterial causes of severe acute respiratory illness among children aged less than 5 years in a high malaria prevalence area of western Kenya, 2007-2010
GHDx Entry last modified on: Jan 12, 2022
First year post PCV13 vaccine introduction in Argentina: a hospital-based pneumonia surveillance in ten pediatric hospital units
GHDx Entry last modified on: Jun 14, 2021
Acute lower respiratory infections in 5 year -old hospitalized patients in Cambodia, a low-income tropical country: clinical characteristics and pathogenic etiology
GHDx Entry last modified on: Jan 12, 2022
A 4 year prospective study to determine risk factors for severe community acquired pneumonia in children in southern China
GHDx Entry last modified on: Mar 3, 2019
Etiology of community-acquired pneumonia in hospitalized patients in Northern Israel
GHDx Entry last modified on: Jan 12, 2022
United States Active Bacterial Core Surveillance Report, Group A Streptococcus 2006
Active Bacterial Core Surveillance (ABCs) Report, Emerging Infections Program Network, Group A Streptococcus, 2006
Do seasonal changes and climate influence the etiology of community acquired pneumonia?
GHDx Entry last modified on: Mar 3, 2019
Perfil etiológico de la neumonía adquirida en la comunidad en niños de 2 a 59 meses en dos zonas ecológicamente distintas del Perú
GHDx Entry last modified on: Mar 3, 2019
Invasive pneumococcal disease in children: late impact of PCV7 and PCV13 vaccine in Belgium
GHDx Entry last modified on: Jun 14, 2021
Subscribe